WSU's $80M Pharma and Biomed Building to Emphasize PGx, Expand Omics Capacity | GenomeWeb

NEW YORK (GenomeWeb News) – Washington State University today will officially open a new Pharmaceutical and Biomedical Sciences building, a $78.6 million facility that will house integrated drug, pharmacogenomics, genomics, imaging, and proteomics research programs and core labs.

The 125,000 square-foot facility in Spokane will also house the College of Pharmacy and will be home to much of the university's biomedical research programs, including resources and staff that are in the process of relocating to the building from WSU's campus in Pullman.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: genetic target for urothelial bladder cancer treatment, and more.

At the Conversation, the University of Oxford's Michael Macklay writes that learning genetic risk of disease is a personal decision.

Two dozen scientific organizations have endorsed the March for Science, according to ScienceInsider.

Researchers in Japan describe a chimpanzee with a chromosomal abnormality similar to human Down syndrome, Mashable reports.